Hepatic Arterial Infusion Chemotherapy vs Transcatheter Arterial Chemoembolization as Adjuvant Therapy Following Surgery for MVI-Positive Hepatocellular Carcinoma: A Multicenter Propensity Score Matching Analysis.
Yuhua WenLianghe LuJie MeiYihong LingRen-Guo GuanWenping LinWei WeiRong-Ping GuoPublished in: Journal of hepatocellular carcinoma (2024)
Compared to a-TACE and the control group, a-HAIC demonstrated greater benefits in preventing tumor recurrence and improving survival in HCC patients with MVI.